180 related articles for article (PubMed ID: 11092686)
1. Preferential consumption of coagulation factors I, V, and VIII in rat endotoxemia.
Yamaguchi K; Majima M; Katori M; Kakita A; Sugimoto K
Shock; 2000 Nov; 14(5):535-43. PubMed ID: 11092686
[TBL] [Abstract][Full Text] [Related]
2. Rhesus differential susceptibility to endotoxin is not associated with activation of plasma prekallikrein.
Veloso D; Smith JI; Cosgriff TM
Immunopharmacology; 1999 Sep; 43(2-3):265-71. PubMed ID: 10596862
[TBL] [Abstract][Full Text] [Related]
3. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
Scott CF; Silver LD; Schapira M; Colman RW
J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
[TBL] [Abstract][Full Text] [Related]
4. Prolonged activated partial thromboplastin time and deficiency of high molecular weight kininogen in brown Norway rat mutant (Katholiek strain).
Oh-ishi S; Hayashi I; Satoh K; Nakano T
Thromb Res; 1984 Feb; 33(4):371-7. PubMed ID: 6710438
[TBL] [Abstract][Full Text] [Related]
5. [Study on changes of blood coagulation factors in rats with hemorrhagic shock].
Zhang YJ; Pan JY; Wang MS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):110-3. PubMed ID: 15748447
[TBL] [Abstract][Full Text] [Related]
6. Hump-nosed pit viper (Hypnale hypnale) envenoming causes mild coagulopathy with incomplete clotting factor consumption.
Maduwage K; Scorgie FE; Silva A; Shahmy S; Mohamed F; Abeysinghe C; Karunathilake H; Lincz LF; Gnanathasan CA; Isbister GK
Clin Toxicol (Phila); 2013 Aug; 51(7):527-31. PubMed ID: 23879180
[TBL] [Abstract][Full Text] [Related]
7. Anti-c5a ameliorates coagulation/fibrinolytic protein changes in a rat model of sepsis.
Laudes IJ; Chu JC; Sikranth S; Huber-Lang M; Guo RF; Riedemann N; Sarma JV; Schmaier AH; Ward PA
Am J Pathol; 2002 May; 160(5):1867-75. PubMed ID: 12000738
[TBL] [Abstract][Full Text] [Related]
8. Activation of factor XII and prekallikrein with cholesterol sulfate.
Shimada T; Kato H; Iwanaga S; Iwamori M; Nagai Y
Thromb Res; 1985 Apr; 38(1):21-31. PubMed ID: 3847226
[TBL] [Abstract][Full Text] [Related]
9. Singlet oxygen inactivates fibrinogen, factor V, factor VIII, factor X, and platelet aggregation of human blood.
Stief TW; Kurz J; Doss MO; Fareed J
Thromb Res; 2000 Mar; 97(6):473-80. PubMed ID: 10704657
[TBL] [Abstract][Full Text] [Related]
10. Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII.
Seligsohn U; Osterud B; Brown SF; Griffin JH; Rapaport SI
J Clin Invest; 1979 Oct; 64(4):1056-65. PubMed ID: 479368
[TBL] [Abstract][Full Text] [Related]
11. The role of bovine high-molecular-weight (HMW) kininogen in contact-mediated activation of bovine factor XII: interaction of HMW kininogen with kaolin and plasma prekallikrein.
Ikari N; Sugo T; Fujii S; Kato H; Iwanaga S
J Biochem; 1981 Jun; 89(6):1699-709. PubMed ID: 6912861
[TBL] [Abstract][Full Text] [Related]
12. Basic mechanisms in blood coagulation.
Davie EW; Fujikawa K
Annu Rev Biochem; 1975; 44():799-829. PubMed ID: 237463
[No Abstract] [Full Text] [Related]
13. Mechanisms for Hageman factor activation and role of HMW kininogen as a coagulation cofactor.
Kaplan AP; Silverberg M; Dunn JT; Miller G
Ann N Y Acad Sci; 1981; 370():253-60. PubMed ID: 6455951
[TBL] [Abstract][Full Text] [Related]
14. Choline or CDP-choline attenuates coagulation abnormalities and prevents the development of acute disseminated intravascular coagulation in dogs during endotoxemia.
Yilmaz Z; Ozarda Y; Cansev M; Eralp O; Kocaturk M; Ulus IH
Blood Coagul Fibrinolysis; 2010 Jun; 21(4):339-48. PubMed ID: 20410813
[TBL] [Abstract][Full Text] [Related]
15. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits.
Bregengård C; Nordfang O; Wildgoose P; Svendsen O; Hedner U; Diness V
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):699-706. PubMed ID: 8292719
[TBL] [Abstract][Full Text] [Related]
16. Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.
Ratnoff OD; Saito H
Proc Natl Acad Sci U S A; 1979 Feb; 76(2):958-61. PubMed ID: 284420
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of the function of Hageman factor fragments by high molecular weight kininogen.
Liu CY; Scott CF; Bagdasarian A; Pierce JV; Kaplan AP; Colman RW
J Clin Invest; 1977 Jul; 60(1):7-17. PubMed ID: 874091
[TBL] [Abstract][Full Text] [Related]
18. Theories of blood coagulation. Properties and interactions of blood clotting factors.
Kazal LA
Ann Clin Lab Sci (1971); 1971; 1(2):139-54. PubMed ID: 4949446
[No Abstract] [Full Text] [Related]
19. Rat coagulation factors V, VIII, XI, and XII: vitamin K dependent.
Owen CA; Bowie EJ
Haemostasis; 1978; 7(4):189-201. PubMed ID: 658784
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of hemorrhagic disorders.
Nemerson Y
Med Clin North Am; 1973 Mar; 57(2):531-41. PubMed ID: 4570937
[No Abstract] [Full Text] [Related]
[Next] [New Search]
